Company Search:
Advanced Search
Sponsored Links
Celon Pharma SA Company Snapshot
Celon Pharma SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Celon Pharma SA with three other pharmaceutical manufacturers in Europe: Summit Therapeutics PLC of the United Kingdom (2018 sales of £25.42 million [US$31.77 million] of which 100% was Drug Discovery), Biosynex SA of France (31.21 million Euro [US$34.56 million] of which 56% was Sale of Goods), and Santhera Pharmaceuticals Holding AG which is based in Switzerland (31.66 million Swiss Francs [US$31.88 million] of which 100% was Pharmaceutical Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Celon Pharma SA
  Stock Performance Chart for Celon Pharma SA
  Stock Data: Recent Stock Performance:
  Current Price (9/20/2019): 41.25
(Figures in Polish New Zlotys)
1 Week 1.9%   13 Weeks 1.1%  
4 Weeks -8.8%   52 Weeks 22.6%  
Celon Pharma SA Key Data:
  Ticker: CLN Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 125,244,805
(Year Ending Jan 2019).
Employees: 297
  Currency: Polish New Zlotys Market Cap: 1,856,250,000
  Fiscal Yr Ends: December Shares Outstanding: 45,000,000
  Share Type: Akcje Closely Held Shares: 30,003,300
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.